-
1
-
-
84962966492
-
-
World Health Organization Geneva
-
1 WHO. Global report on diabetes, 2016, World Health Organization, Geneva.
-
(2016)
Global report on diabetes
-
-
-
2
-
-
0030935652
-
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da 2Qing IGT and diabetes study
-
2 Pan, XR, Hu, YH, Wang, JX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da 2Qing IGT and diabetes study. Diabetes Care 20 (1997), 537–544.
-
(1997)
Diabetes Care
, vol.20
, pp. 537-544
-
-
Pan, X.R.1
Hu, Y.H.2
Wang, J.X.3
-
3
-
-
0037034257
-
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
3 Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
-
(2002)
N Engl J Med
, vol.346
, pp. 393-403
-
-
-
4
-
-
84874317398
-
Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)
-
4 Lindström, J, Peltonen, M, Eriksson, JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56 (2013), 284–293.
-
(2013)
Diabetologia
, vol.56
, pp. 284-293
-
-
Lindström, J.1
Peltonen, M.2
Eriksson, J.G.3
-
5
-
-
78951479529
-
Long-term effects of a randomised trial of 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
-
5 Gong, Q, Gregg, EW, Wang, J, et al. Long-term effects of a randomised trial of 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54 (2011), 300–307.
-
(2011)
Diabetologia
, vol.54
, pp. 300-307
-
-
Gong, Q.1
Gregg, E.W.2
Wang, J.3
-
6
-
-
84945463952
-
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
-
6 Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3 (2015), 866–875.
-
(2015)
Lancet Diabetes Endocrinol
, vol.3
, pp. 866-875
-
-
-
7
-
-
84901590227
-
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up
-
7 Li, G, Zhang, P, Wang, J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up. Lancet Diabetes Endocrinol 2 (2014), 474–480.
-
(2014)
Lancet Diabetes Endocrinol
, vol.2
, pp. 474-480
-
-
Li, G.1
Zhang, P.2
Wang, J.3
-
8
-
-
84880323061
-
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
-
8 The Look AHEAD Study Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369 (2013), 145–154.
-
(2013)
N Engl J Med
, vol.369
, pp. 145-154
-
-
-
9
-
-
84993315699
-
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
-
published online Aug 30.
-
9 The Look AHEAD Research Group. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol, 2016 published online Aug 30. http://dx.doi.org/10.1016/S2213-8587(16)30162-0.
-
(2016)
Lancet Diabetes Endocrinol
-
-
-
10
-
-
66249112528
-
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial
-
10 Uusitupa, M, Peltonen, M, Lindström, J, et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial. PLoS One, 4, 2009, e5656.
-
(2009)
PLoS One
, vol.4
, pp. e5656
-
-
Uusitupa, M.1
Peltonen, M.2
Lindström, J.3
|